REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 111 filers reported holding REVANCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $886,329 | -41.4% | 180,148 | +4.7% | 0.00% | 0.0% |
| Q4 2023 | $1,511,941 | -6.3% | 172,007 | +22.3% | 0.00% | -50.0% |
| Q3 2023 | $1,612,854 | -55.2% | 140,615 | -1.1% | 0.00% | -50.0% |
| Q2 2023 | $3,598,778 | -19.5% | 142,188 | +2.4% | 0.00% | -20.0% |
| Q1 2023 | $4,472,229 | +86.4% | 138,846 | +6.8% | 0.01% | +66.7% |
| Q4 2022 | $2,399,892 | -8.6% | 130,005 | +33.7% | 0.00% | 0.0% |
| Q3 2022 | $2,625,000 | +109.2% | 97,253 | +7.0% | 0.00% | +200.0% |
| Q2 2022 | $1,255,000 | -29.0% | 90,877 | +0.2% | 0.00% | -50.0% |
| Q1 2022 | $1,767,000 | +27.4% | 90,653 | +6.7% | 0.00% | +100.0% |
| Q4 2021 | $1,387,000 | -42.2% | 84,970 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $2,398,000 | -1.7% | 86,056 | +4.6% | 0.00% | 0.0% |
| Q2 2021 | $2,440,000 | +1.6% | 82,295 | -4.2% | 0.00% | 0.0% |
| Q1 2021 | $2,401,000 | -21.2% | 85,902 | -20.1% | 0.00% | 0.0% |
| Q4 2020 | $3,047,000 | +114.9% | 107,500 | +90.6% | 0.00% | 0.0% |
| Q3 2020 | $1,418,000 | +17.4% | 56,391 | +14.0% | 0.00% | 0.0% |
| Q2 2020 | $1,208,000 | +37.1% | 49,464 | -16.9% | 0.00% | 0.0% |
| Q1 2020 | $881,000 | +55.1% | 59,540 | +70.1% | 0.00% | – |
| Q4 2019 | $568,000 | +61.4% | 35,012 | +29.5% | 0.00% | – |
| Q3 2019 | $352,000 | -6.4% | 27,045 | -6.8% | 0.00% | – |
| Q2 2019 | $376,000 | +0.8% | 29,007 | +22.8% | 0.00% | – |
| Q1 2019 | $373,000 | -6.3% | 23,629 | +19.5% | 0.00% | – |
| Q4 2018 | $398,000 | -7.7% | 19,780 | +14.2% | 0.00% | – |
| Q3 2018 | $431,000 | -36.8% | 17,318 | -30.2% | 0.00% | -100.0% |
| Q2 2018 | $682,000 | -13.5% | 24,809 | -3.0% | 0.00% | 0.0% |
| Q1 2018 | $788,000 | -21.4% | 25,575 | -8.9% | 0.00% | 0.0% |
| Q4 2017 | $1,002,000 | +49.6% | 28,066 | +15.2% | 0.00% | 0.0% |
| Q3 2017 | $670,000 | +101.8% | 24,373 | +93.3% | 0.00% | – |
| Q2 2017 | $332,000 | +21.2% | 12,606 | -4.3% | 0.00% | – |
| Q1 2017 | $274,000 | -26.7% | 13,166 | -27.2% | 0.00% | – |
| Q4 2016 | $374,000 | +0.8% | 18,078 | -21.0% | 0.00% | – |
| Q3 2016 | $371,000 | +9.8% | 22,886 | -7.9% | 0.00% | – |
| Q2 2016 | $338,000 | -50.7% | 24,852 | -36.7% | 0.00% | -100.0% |
| Q1 2016 | $685,000 | +19.3% | 39,283 | +133.7% | 0.00% | 0.0% |
| Q4 2015 | $574,000 | +33.5% | 16,806 | +16.2% | 0.00% | 0.0% |
| Q3 2015 | $430,000 | -63.7% | 14,461 | -61.0% | 0.00% | 0.0% |
| Q2 2015 | $1,186,000 | +124.2% | 37,098 | +45.5% | 0.00% | 0.0% |
| Q1 2015 | $529,000 | -16.4% | 25,494 | -31.8% | 0.00% | 0.0% |
| Q4 2014 | $633,000 | +77.3% | 37,408 | +102.5% | 0.00% | – |
| Q3 2014 | $357,000 | +48.8% | 18,473 | +161.4% | 0.00% | – |
| Q2 2014 | $240,000 | – | 7,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |